A mucoadhesive in situ gel delivery system for paclitaxel

AAPS PharmSciTech

Volumn 7, Issue 2, 2006, Pages

  Jauhari, Saurabh ^a   Dash, Alekha K ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Caco 2; Calu 3; In situ gel; Mucin; Paclitaxel

Indexed keywords

ANTINEOPLASTIC AGENT; BUFFER; CHITOSAN; CITRIC ACID; GLYCEROL OLEATE; GLYCOPROTEIN; MUCIN 1; PACLITAXEL; PHOSPHATE; POLYSORBATE 80; SURFACTANT;

ARTICLE; BREAST CANCER; CELL STRAIN CACO 2; COLON CANCER; CONTROLLED STUDY; DIFFUSION CHAMBER; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG TRANSPORT; GEL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOLAYER CULTURE; PH; TEMPERATURE;

EID: 33745108769     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt070231     Document Type: Article

References (21)

1. Gendler SJ. MUC 1, the renaissance molecule. J Mammary Gland Biol Neoplasia. 2001;6:339-353.
2. Schroeder JA, Thompson MC, Gardner MM, Gendler S. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J Biol Chem. 2001;276:13057-13064.
3. Hamada T, Matsukita S, Goto M, et al. Mucin expression in pleomorphic adenoma of salivarygland: a potential role for MUC1 as a marker to predict recurrence. J Clin Pathol. 2004;57:813-821.
4. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA. 1980;77:1561-1565.
5. Schiff PB, Horwitz SB. Promotion of microtubule assembly in vitro by Taxol. Nature. 1979;277:665-667.
6. 1, mice. Can Chemother Pharmacol. 1994;34:465-471.
7. Brooks TA, Minderman H, O'Loughlin KL, et al. Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistant protein, and breast cancer resistance protein. Mol Cancer Ther. 2003;2:1195-1205.
8. Trissel LA. Pharmaceutical properties of paclitaxel and their effects on preparation and administration. Pharmacotherapy. 1997;17:133s-139s.
9. Chandy T, Sharma CP. Chitosan - as a biomaterial. Biomater Artil Cells Artif Organs. 1990; 18:1-24.
10. Fiebrig I, Harding SE, Rowe AJ, Hyman SC, Davis SS. Transmission electron microscopy on pig gastric mucin and its interaction with chitosan. Carbohydr Polym. 1995;28:239-244.
11. He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm. 1998;166:75-88.
12. Lueßen HL, Lehr CM, Rentel CO, et al. Bioadhesive polymers for the peroral delivery of peptides drugs. J Control Release. 1994;29:329-338.
13. Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev. 2001;47:229-250.
14. Dash AK, Gong Z, Miller DW, Huai-Yan H, Laforet J. Development of a rectal nicotine delivery system for the treatment of ulcerative colitis. Int J Pharm. 1999;190:21-34.
15. Nielsen LS, Schubert L, Hansen J. Bioadhesive drug delivery systems in characterization of mucoadhesive properties of systems based on glyceryl monooleate and glyceryl monolinoleate. Eur J Pharm Sci. 1998;6:231-239.
16. Ganguly S, Dash AK. A novel in situ gel for sustained drug delivery and targeting. Int J Pharm. 2004;276:83-92.
17. Dash AK, Miller DW, Huai-Yan H, Carnazzo J, Stout JR. Evaluation of creatine transport using Caco-2 monolayers as an in vitro model for intestinal absorption. J Pharm Sci. 200 1;90:1593-1598.
18. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspensions. J Pharm Sci. 1961;50:874-875.
19. Cho YW, Lee J, Lee SC, Huh KM, Park K. Hydrotropic agents for study of in vitro Paclitaxel release from polymeric micelles. J Control Release. 2004;97:249-257.
20. Walle UK, Walle T. Taxol transport by human intestinal epithelial Caco-2 cells. Drug Metab Dispos. 1998;26:343-346.
21. Hamilton KO, Backstrom G, Yazdanian MA, Audus KL. P-glycoprotein efflux pump expression and activity in Calu-3 cells. J Pharm Sci. 2001;90:647-658.